Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease. Mederi Therapeutics holds over 80 patents in the use of RF energy for treatment of disease states affecting the human digestive system. The first two products — Secca, for treatment of bowel incontinence or BCD (bowel control disorder) and Stretta, for treatment of gastroesophageal reflux disease (GERD) — have demonstrated clinical effectiveness in numerous studies. All Mederi therapies are outpatient (same day), minimally invasive (no incisions) and promote rapid recovery for patients. Mederi Therapeutics is located in Greenwich, Connecticut.